These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25805821)

  • 61. The membranes of Gram-negative bacteria: progress in molecular modelling and simulation.
    Khalid S; Berglund NA; Holdbrook DA; Leung YM; Parkin J
    Biochem Soc Trans; 2015 Apr; 43(2):162-7. PubMed ID: 25849911
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of glycoproteins containing specific glycans using a lectin-chemical method.
    Li Y; Shah P; De Marzo AM; Van Eyk JE; Li Q; Chan DW; Zhang H
    Anal Chem; 2015; 87(9):4683-7. PubMed ID: 25837443
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of N-glycosylation in EGFR ectodomain ligand binding.
    Azimzadeh Irani M; Kannan S; Verma C
    Proteins; 2017 Aug; 85(8):1529-1549. PubMed ID: 28486782
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function.
    Lam D; Arroyo B; Liberchuk AN; Wolfe AL
    bioRxiv; 2024 Jul; ():. PubMed ID: 39071333
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation.
    Trenker R; Diwanji D; Bingham T; Verba KA; Jura N
    Elife; 2024 Mar; 12():. PubMed ID: 38498590
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of
    Lin Y; Lubman DM
    Acta Pharm Sin B; 2024 Mar; 14(3):1098-1110. PubMed ID: 38486989
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation.
    Trenker R; Diwanji D; Bingham T; Verba KA; Jura N
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260342
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases.
    Tao M; Shi Y; Chen H; Li J; Wang Y; Ma X; Du L; Wang Y; Yang X; Hu Y; Zhou X; Zhong Q; Yan D; Qiu A; Zhuang S; Liu N
    Mol Biomed; 2024 Jan; 5(1):3. PubMed ID: 38172378
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics.
    Ankenbauer KE; Rao TC; Mattheyses AL; Bellis SL
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398202
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of aberrant glycosylation associated with osteoarthritis based on integrated glycomics methods.
    Yu H; Li M; Shu J; Dang L; Wu X; Wang Y; Wang X; Chang X; Bao X; Zhu B; Ren X; Chen W; Li Y
    Arthritis Res Ther; 2023 Jun; 25(1):102. PubMed ID: 37308935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. EGFR and p38
    Dena-Beltrán JL; Nava-Domínguez P; Palmerín-Carreño D; Martínez-Alarcón D; Moreno-Celis U; Valle-Pacheco M; Castro-Guillén JL; Blanco-Labra A; García-Gasca T
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259433
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Metabolite-derived protein modifications modulating oncogenic signaling.
    Liu Y; Vandekeere A; Xu M; Fendt SM; Altea-Manzano P
    Front Oncol; 2022; 12():988626. PubMed ID: 36226054
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure of POPC Lipid Bilayers in OPLS3e Force Field.
    Kurki M; Poso A; Bartos P; Miettinen MS
    J Chem Inf Model; 2022 Dec; 62(24):6462-6474. PubMed ID: 36044537
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma.
    Rosa-Fernandes L; Oba-Shinjo SM; Macedo-da-Silva J; Marie SKN; Palmisano G
    Adv Exp Med Biol; 2022; 1382():39-70. PubMed ID: 36029403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain.
    Di Liddo R; Verona M; Vaccarin C; Acquasaliente L; Schrenk S; Piccione M; Cenzi C; De Franco M; Dal Prà M; Ribaudo G; Ferlin MG; Conconi MT; Chilin A; Gandin V; Marzaro G
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mechanisms of Natural Extracts of
    Naomi R; Bahari H; Ong ZY; Keong YY; Embong H; Rajandram R; Teoh SH; Othman F; Hasham R; Yin KB; Kaniappan P; Yazid MD; Zakaria ZA
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682652
    [No Abstract]   [Full Text] [Related]  

  • 77. It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases.
    Kovacs T; Zakany F; Nagy P
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205690
    [TBL] [Abstract][Full Text] [Related]  

  • 78. C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma.
    Lin NY; Chen ST; Chang HL; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Huang MC; Chang HH
    Oncogenesis; 2022 Feb; 11(1):8. PubMed ID: 35169131
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of glycosyltransferases in carcinogenesis; growth factor signaling and EMT/MET programs.
    Takahashi M; Hasegawa Y; Maeda K; Kitano M; Taniguchi N
    Glycoconj J; 2022 Apr; 39(2):167-176. PubMed ID: 35089466
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Substratum stiffness regulates Erk signaling dynamics through receptor-level control.
    Farahani PE; Lemke SB; Dine E; Uribe G; Toettcher JE; Nelson CM
    Cell Rep; 2021 Dec; 37(13):110181. PubMed ID: 34965432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.